{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:39:08Z","timestamp":1790519948895,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005370.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T00:00:00Z","timestamp":1454976000000}}],"reference-count":101,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005370.pub3","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T12:41:51Z","timestamp":1455021711000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antithrombin III for critically ill patients"],"prefix":"10.1002","volume":"2018","author":[{"given":"Mikkel","family":"Allingstrup","sequence":"first","affiliation":[{"name":"Rigshospitalet, Copenhagen University Hospital; Juliane Marie Centre - Anaesthesia and Surgical Clinic Department 4013; Copenhagen Denmark"},{"name":"Rigshospitalet, Copenhagen University Hospital; Department of Paediatric and Obstetric Anaesthesia; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rn","family":"Wetterslev","sequence":"additional","affiliation":[{"name":"Department 7812, Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederikke B","family":"Ravn","sequence":"additional","affiliation":[{"name":"Rigshospitalet; Department of Paediatric and Obstetric Anaesthesia; Blegdamsvej 9, Afsnit 3342, rum 52 Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Merete","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Herlev and Gentofte Hospital, University of Copenhagen; Cochrane Anaesthesia, Critical and Emergency Care Group; Herlev Ringvej Herlev Denmark 2730"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Afshari","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Copenhagen University Hospital; Juliane Marie Centre - Anaesthesia and Surgical Clinic Department 4013; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,2,9]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD005370.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1399-6576.1992.tb03557.x","article-title":"Effect of antithrombin concentrate on haemostatic variables in critically ill patients","volume":"36","author":"Albert","year":"1992","journal-title":"Acta Anaesthesiologica Scandinavia"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0002|cit2","first-page":"17","article-title":"Prospective double blind placebo-controlled trial of ATIII substitution in sepsis","volume":"21 Suppl 1","author":"Balk","year":"1995","journal-title":"Intensive Care Medicine"},{"issue":"4-5","key":"10.1002\/14651858.CD005370.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0049-3848(92)90099-V","article-title":"Antithrombin III supplementation during orthotopic liver transplantation in cirrhotic patients: a randomized trial","volume":"68","author":"Baudo","year":"1992","journal-title":"Thrombosis Research"},{"issue":"4","key":"10.1002\/14651858.CD005370.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s001340050576","article-title":"Antithrombin III (ATIII) replacement therapy in patients with severe sepsis and\/or postsurgical complications: a controlled double-blind, randomized, multicenter study","volume":"24","author":"Baudo","year":"1998","journal-title":"Intensive Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0049-3848(85)90123-9","article-title":"Substitution of antithrombin III in shock and DIC: a randomized study","volume":"39","author":"Blauhut","year":"1985","journal-title":"Thrombosis Research"},{"issue":"8","key":"10.1002\/14651858.CD005370.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF01705725","article-title":"Use of antithrombin III in critical patients","volume":"20","author":"Diaz-Cremades","year":"1994","journal-title":"Intensive Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD005370.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s001340050642","article-title":"Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis.","volume":"24","author":"Eisele","year":"1998","journal-title":"Intensive Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005370.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1378\/chest.104.3.882","article-title":"Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation","volume":"104","author":"Fourrier","year":"1993","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000067005","article-title":"Can the administration of antithrombin III decrease the risk of cerebral hemorrhage in premature infants?","volume":"83","author":"Fulia","year":"2003","journal-title":"Biology of the Neonate"},{"issue":"6","key":"10.1002\/14651858.CD005370.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/cc13163","article-title":"A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis","volume":"17","author":"Gando","year":"2013","journal-title":"Critical Care"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0011|cit11","unstructured":"UMIN-CTR Clinical Trial Trial registration upload.umin.ac.jp\/cgi-open-bin\/ctr\/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000001064&language=E"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00008506-200101000-00010","article-title":"Antithrombin treatment in patients with traumatic brain Injury; a pilot study","volume":"13","author":"Grenander","year":"2001","journal-title":"Journal of Neurosurgical Anesthesiology"},{"issue":"3","key":"10.1002\/14651858.CD005370.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1083-8791(98)50003-1","article-title":"A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation","volume":"4","author":"Haire","year":"1998","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005370.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-3148.1991.tb00020.x","article-title":"A pilot study of antithrombin replacement in intensive care management: the effects on mortality, coagulation and renal function","volume":"1","author":"Harper","year":"1991","journal-title":"Transfusion Medicine"},{"issue":"9","key":"10.1002\/14651858.CD005370.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/01.CCM.0000139691.54108.1F","article-title":"Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis","volume":"32","author":"Hoffmann","year":"2004","journal-title":"Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005370.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00024382-199711000-00003","article-title":"Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction","volume":"8","author":"Inthorn","year":"1997","journal-title":"Shock"},{"issue":"2","key":"10.1002\/14651858.CD005370.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00024382-199808000-00002","article-title":"Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis","volume":"10","author":"Inthorn","year":"1998","journal-title":"Shock"},{"issue":"6","key":"10.1002\/14651858.CD005370.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/s-2004-815632","article-title":"Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study","volume":"29","author":"Kobayashi","year":"2003","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"3","key":"10.1002\/14651858.CD005370.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0168-8278(05)80213-2","article-title":"Controlled trial of antithrombin III supplementation in fulminant hepatic failure","volume":"17","author":"Langley","year":"1993","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD005370.pub3-BIB0020|cit20","first-page":"286-90","article-title":"The efficacy of antithrombin administration in the acute phase of burn injury.","volume":"100","author":"Lavrentieva","year":"2008","journal-title":"Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD005370.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1055\/s-0037-1614071","article-title":"Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial","volume":"84","author":"Maki","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"34-9","DOI":"10.1111\/j.1447-0756.2007.00677.x","article-title":"Antithrombin improves fetal condition in women with severe pre-eclampsia before 32 weeks of gestation;a randomized, double-blind, placebo-controlled trial","volume":"34","author":"Sameshima","year":"2008","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"2","key":"10.1002\/14651858.CD005370.pub3-BIB0023|cit23","first-page":"235","article-title":"Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study","volume":"90","author":"Mitchell","year":"2003","journal-title":"Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD005370.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/cncr.11042","article-title":"A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase - Results of the prophylactic antithrombin replacement in kids with acute lymphoblastic leukemia treated with asparaginase (PARKAA) study","volume":"97","author":"Mitchell","year":"2003","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0025|cit25","first-page":"288","article-title":"Antithrombin III concentrate in preterm infants with IRDS: an open, controlled, randomized clinical trial (abstract)","volume":"62","author":"Muntean","year":"1989","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.15360\/1813-9779-2008-5-49","article-title":"Antithrombin III deficiency correction in patients with disseminated intravascular coagulation","volume":"5","author":"Neporada","year":"2008","journal-title":"Obshaya Reanimatologia"},{"issue":"7","key":"10.1002\/14651858.CD005370.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1219-23","DOI":"10.1016\/j.ajem.2011.06.003","article-title":"Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.","volume":"30","author":"Nishiyama","year":"2012","journal-title":"American Journal of Emergency Medicine"},{"issue":"6","key":"10.1002\/14651858.CD005370.pub3-BIB0028|cit28","first-page":"1251","article-title":"Laboratory effects of antithrombin-III (ATIII) replacement in patients with sepsis and or postsurgical complications requiring hemodynamic and or respiratory support - a controlled, double-blind, randomized multicenter study","volume":"73","author":"Palareti","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD005370.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1164\/ajrccm.158.2.9712116","article-title":"A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome","volume":"158","author":"Schmidt","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD005370.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2362.2000.00630.x","article-title":"Antithrombin III and local serum application: adjuvant therapy in peritonitis","volume":"30","author":"Schorr","year":"2000","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0031|cit31","first-page":"76","article-title":"S-AT III study: antithrombin III in patients with sepsis","volume":"23 Suppl 1","author":"Schuster","year":"1997","journal-title":"Intensive Care Medicine"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/tcic.7.6.291.296","article-title":"The effect of antithrombin III substitution therapy on components of the plasma protease systems in surgical patients","volume":"7","author":"Smith-Erichsen","year":"1996","journal-title":"Clinical Intensive Care"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0033|cit33","first-page":"42","article-title":"Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation","volume":"2","author":"Vorob'eva","year":"2007","journal-title":"Anesteziologiia i Reanimatologiia"},{"issue":"2","key":"10.1002\/14651858.CD005370.pub3-BIB0034|cit34","first-page":"171-9","article-title":"Severe sepsis and disseminated intravascular coagulation. Supplementation with antithrombin","volume":"58","author":"Angstwurm","year":"2009","journal-title":"Anaesthesist"},{"issue":"5","key":"10.1002\/14651858.CD005370.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1213\/ane.0b013e318184621d","article-title":"Early administration of high-dose antithrombin in severe sepsis: single center results from the KyberSept-trial","volume":"107","author":"Eid","year":"2008","journal-title":"Anesthesia and Analgesia"},{"issue":"6","key":"10.1002\/14651858.CD005370.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/cc5098","article-title":"Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis","volume":"10","author":"Gonano","year":"2006","journal-title":"Critical Care"},{"issue":"5","key":"10.1002\/14651858.CD005370.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1160\/TH05-07-0530","article-title":"Benefit\/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin","volume":"95","author":"Hoffmann","year":"2006","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1538-7836.2005.01697.x","article-title":"Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation","volume":"4","author":"Kienast","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD005370.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/cc1529","article-title":"Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]","volume":"6","author":"Rublee","year":"2002","journal-title":"Critical Care"},{"issue":"5","key":"10.1002\/14651858.CD005370.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/01.CCM.0000059724.08290.51","article-title":"Lipoprotein metabolism in patients with severe sepsis","volume":"31","author":"Leeuwen","year":"2003","journal-title":"Critical Care Medicine"},{"issue":"15","key":"10.1002\/14651858.CD005370.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High-dose antithrombin III in severe sepsis, a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD005370.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.CCM.0000194731.08896.99","article-title":"High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety","volume":"34","author":"Wiedermann","year":"2006","journal-title":"Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005370.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00005373-199811000-00015","article-title":"High-dose antithrombin III treatment of severely injured patients: results of a prospective study","volume":"45","author":"Waydhas","year":"1998","journal-title":"Journal of Trauma, Injury, Infection and Critical Care"},{"issue":"2","key":"10.1002\/14651858.CD005370.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/shk.0b013e31803422c4","article-title":"Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study","volume":"28","author":"Aibiki","year":"2007","journal-title":"Shock"},{"issue":"6","key":"10.1002\/14651858.CD005370.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1213\/ANE.0b013e31827d0f6b","article-title":"The influence of antithrombin substitution on heparin sensitivity and activation of hemostasis during coronary artery bypass graft surgery: a dose-finding study","volume":"116","author":"Dietrich","year":"2013","journal-title":"Anesthesia and Analgesia"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0046|cit46","first-page":"198","article-title":"Analysis of the anti-inflammatory effects of antithrombin III on human platelets","volume":"1","author":"Doi","year":"2012","journal-title":"7th Congress of the International Federation of Shock Societies - 35th Annual Conference on Shock Miami Beach, FL United States"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0047|cit47","doi-asserted-by":"crossref","unstructured":"Hoffmann JN Fertmann JM Illner W Arbogast H Land H Jauch K High-dose antithrombin can not improve kidney function despite improved graft perfusion in human kidney transplantation-final results of a prospective, controlled trial 23rd International Congress of the Transplantation Society, TTS 2010 Vancouver, BC Canada 2010 1882","DOI":"10.1097\/00007890-201007272-00199"},{"issue":"6","key":"10.1002\/14651858.CD005370.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s001340051236","article-title":"Antithrombin III in patients with severe sepsis: a pharmacokinetic study","volume":"26","author":"Ilias","year":"2000","journal-title":"Intensive Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD005370.pub3-BIB0049|cit49","first-page":"19","article-title":"Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation","volume":"32 Suppl 2","author":"Jochum","year":"1995","journal-title":"Seminars in Hematology"},{"issue":"7","key":"10.1002\/14651858.CD005370.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/MBC.0b013e32834a0478","article-title":"Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity andcoagulation during nitroglycerine infusion in coronary artery bypass surgery","volume":"22","author":"Kanbak","year":"2011","journal-title":"Blood Coagulation and Fibrinolysis"},{"issue":"11","key":"10.1002\/14651858.CD005370.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.clinthera.2013.08.018","article-title":"Bioequivalence of two intravenous formulations of antithrombin III: a two-way crossover study in healthy Korean subjects","volume":"35","author":"Kim","year":"2013","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0052|cit52","first-page":"426","article-title":"Randomized trial of antithrombin-III versus placebo in patients undergoing peritoneo-venous shunt operation","volume":"58","author":"Korninger","year":"1987","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clpt.2005.10.003","article-title":"Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia","volume":"79","author":"Leitner","year":"2006","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD005370.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000298866","article-title":"Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial","volume":"23","author":"Maki","year":"1987","journal-title":"Gynecology and Obstetric Investigation"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0055|cit55","unstructured":"Mayumi T Suzuki S Yamamoto T Ichikawa T Onodera M Tsuzuki M Levels of antithrombin activity after antithrombin administration indicate prognosis of septic DIC patients Shock Society 2011 www.shocksociety.org\/assets\/docs\/shock%202011%20oral%20abstracts.pdf"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0056|cit56","first-page":"47","article-title":"Antithrombin III concentrate in comparison with FFP in patients with disseminated intravascular coagulation","volume":"7","author":"Neporada","year":"2008","journal-title":"Human Ecology"},{"issue":"4","key":"10.1002\/14651858.CD005370.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1213\/01.ane.0000202396.22352.01","article-title":"Antithrombin can modulate coagulation, cytokine production, and expression of adhesion molecules in abdominal aortic aneurysm repair surgery","volume":"102","author":"Nishiyama","year":"2006","journal-title":"Anesthesia and Analgesia"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0058|cit58","unstructured":"NCT01201070 Trial registration clinicaltrials.gov\/ct2\/show\/NCT01201070"},{"issue":"4","key":"10.1002\/14651858.CD005370.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.athoracsur.2013.11.040","article-title":"Antithrombin administration in patients with low antithrombin values after cardiac surgery: a randomized controlled trial","volume":"97","author":"Paparella","year":"2014","journal-title":"Annals of Thoracic Surgery"},{"issue":"2","key":"10.1002\/14651858.CD005370.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0020-7292(00)00268-X","article-title":"Treatment with antithrombin III (AT III) concentrate in pre-eclampsia","volume":"71","author":"Paternoster","year":"2000","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD005370.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1160\/TH03-06-0388","article-title":"Efficacy of AT in pre-eclampsia: a case-control prospective trial","volume":"91","author":"Paternoster","year":"2004","journal-title":"Thrombosis and Haemostasis"},{"issue":"5","key":"10.1002\/14651858.CD005370.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jtcvs.2012.09.061","article-title":"Preoperative antithrombin supplementation in cardiac surgery: a randomized controlled trial","volume":"145","author":"Ranucci","year":"2013","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"issue":"5","key":"10.1002\/14651858.CD005370.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/1076029608323497","article-title":"Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness","volume":"15","author":"Sawamura","year":"2009","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"issue":"11","key":"10.1002\/14651858.CD005370.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/s001340050472","article-title":"The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease","volume":"23","author":"Scherer","year":"1997","journal-title":"Intensive Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005370.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0049-3848(94)90003-5","article-title":"Modulation of coagulation and fibrinolysis in hepatic resection: a randomized prospective control study using antithrombin III concentrates","volume":"74","author":"Shimada","year":"1994","journal-title":"Thrombosis Research"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1447-0756.1989.tb00147.x","article-title":"Pathological state of the coagulatory and fibrinolytic system in preeclampsia and the possibility of its treatment","volume":"15","author":"Terao","year":"1988","journal-title":"Asia-Oceania Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0067|cit67","first-page":"297","article-title":"High-dose antithrombin supplementation in early pre-eclampsia: a double-blind, placebo controlled study (on behalf of the ATIII-EPAS study group)","volume":"7","author":"Valsecchi","year":"2009","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/107602969500100110","article-title":"Antithrombin III in shock and disseminate intravascular coagulation","volume":"1","author":"Vinazzer","year":"1995","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005370.pub3-BIB0069|cit69","first-page":"117","article-title":"A double-blind trial of high-dose antithrombin supplementation in early pre-eclampsia","volume":"115","author":"D'angelo","year":"2005","journal-title":"Thrombosis Research"},{"issue":"7382","key":"10.1002\/14651858.CD005370.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD005370.pub3-BIB0071|cit71","first-page":"160","article-title":"Endothelial function and hemostasis","volume":"89","author":"Becker","year":"2000","journal-title":"Zeitschrift fur Kardiologie"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"20","key":"10.1002\/14651858.CD005370.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.291.20.2457","article-title":"Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles","volume":"291","author":"Chan","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD005370.pub3-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jpeds.2015.06.006","article-title":"Antithrombin concentrate use in children receiving unfractionated heparin for acute thrombosis","volume":"167","author":"Diaz","year":"2015","journal-title":"Journal of Pediatrics"},{"issue":"9 Suppl","key":"10.1002\/14651858.CD005370.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1097\/00003246-200009001-00009","article-title":"Clinical trial results with antithrombin III in sepsis","volume":"28","author":"Fourrier","year":"2000","journal-title":"Critical Care Medicine"},{"issue":"7261","key":"10.1002\/14651858.CD005370.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/bmj.321.7261.585","article-title":"Why we need a broad perspective on meta-analysis. It may be crucially important for patients","volume":"321","author":"Gotzsche","year":"2000","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD005370.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"15","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0078|cit78","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org 10.1002\/9780470712184"},{"issue":"3","key":"10.1002\/14651858.CD005370.pub3-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/1467-9876.00197","article-title":"Bias in meta-analysis due to outcome variable selection within studies","volume":"49","author":"Hutton","year":"2000","journal-title":"Journal of the Royal Statistical Society Series"},{"issue":"3","key":"10.1002\/14651858.CD005370.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2307\/2336502","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika"},{"issue":"15","key":"10.1002\/14651858.CD005370.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"11996","DOI":"10.1074\/jbc.M010170200","article-title":"A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity","volume":"276","author":"Larsson","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/07853890310017251","article-title":"New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology","volume":"36","author":"Levi","year":"2004","journal-title":"Annals of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"Mayr","year":"2014","journal-title":"Virulence"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD005370.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1097\/00003246-200205001-00024","article-title":"Antithrombin, heparin, and heparan sulfate","volume":"30","author":"Opal","year":"2002","journal-title":"Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD005370.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.shk.0000084343.58020.57","article-title":"Clinical trial design and outcomes in patients with severe sepsis","volume":"20","author":"Opal","year":"2003","journal-title":"Shock"},{"issue":"6","key":"10.1002\/14651858.CD005370.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1517\/14656566.1.6.1203","article-title":"Current treatment of sepsis and endotoxaemia","volume":"1","author":"Periti","year":"2000","journal-title":"Expert opinion of Pharmacotherapy"},{"issue":"6","key":"10.1002\/14651858.CD005370.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0197-2456(97)00051-2","article-title":"Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis","volume":"18","author":"Pogue","year":"1997","journal-title":"Controlled Clinical Trials"},{"issue":"9095","key":"10.1002\/14651858.CD005370.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0140-6736(97)08461-4","article-title":"Overcoming the limitations of current meta-analysis of randomised controlled trials","volume":"351","author":"Pogue","year":"1998","journal-title":"Lancet"},{"issue":"9422","key":"10.1002\/14651858.CD005370.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(04)16259-4","article-title":"Drug intervention trials in sepsis: divergent results","volume":"363","author":"Polderman","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005370.pub3-BIB0090|cit90","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD005370.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/cc1529","article-title":"Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial","volume":"Aug; 6","author":"Rublee","year":"2002","journal-title":"Critical Care"},{"issue":"9","key":"10.1002\/14651858.CD005370.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1470-9","DOI":"10.1111\/jth.12643","article-title":"Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study","volume":"12","author":"Tagami","year":"September 2014","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD005370.pub3-BIB0093|cit93","first-page":"537","article-title":"Supplemental dose of antithrombin use in disseminated intravascular coagulation patientsafter abdominal sepsis","volume":"114","author":"Tagami","year":"2015","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD005370.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD005370.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"30","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"3","key":"10.1002\/14651858.CD005370.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1563-2571.2002.02012.x","article-title":"The anti-inflammatory actions of antithrombin - a review","volume":"29","author":"Wiedermann","year":"2002","journal-title":"Acta Medica Austriaca"},{"issue":"10","key":"10.1002\/14651858.CD005370.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1097\/CCM.0b013e318186aec8","article-title":"Variation in critical care services across North America and Western Europe","volume":"36","author":"Wunsch","year":"2008","journal-title":"Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005370.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"511-8","DOI":"10.1097\/CCM.0000000000000763","article-title":"The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis","volume":"43","author":"Zarychanski","year":"2015","journal-title":"Critical Care Medicine"},{"issue":"7632","key":"10.1002\/14651858.CD005370.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/bmj.39398.682500.25","article-title":"Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis","volume":"335","author":"Afshari","year":"2007","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD005370.pub3-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005370.pub2","article-title":"Antithrombin III for critically ill patients","author":"Afshari","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005370.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T07:43:29Z","timestamp":1718351009000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005370.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Emergency and Critical Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,9]]},"references-count":101,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005370.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,9]]}}}